Bill
Bill > A2278
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
The bill clarifies that the standing order authorizing any person or entity to distribute opioid antidotes under current law is to authorize the distribution of any opioid antidote approved by the United States Food and Drug Administration. The bill provides that any program approved by the State for the distribution of opioid antidotes will be authorized to distribute any opioid antidote approved by the United States Food and Drug Administration.
AI Summary
This bill clarifies that a standing order, which is a directive from a medical professional allowing others to distribute medication, authorizing any person or entity to distribute opioid antidotes, also permits the distribution of any opioid antidote that has been approved by the United States Food and Drug Administration (FDA). Additionally, it specifies that any program approved by the State for distributing opioid antidotes will be authorized to distribute any FDA-approved opioid antidote. This aims to broaden access to life-saving overdose reversal medications.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Introduced, Referred to Assembly Health Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/A2278 |
| BillText | https://pub.njleg.gov/Bills/2026/A2500/2278_I1.HTM |
Loading...